AUS
NZ
UK
CA
USA
IND
Healthcare
What Triggered the Sharp Fall in Cochlear Shares?
April 23, 2026 08:41 PM AEST| By SamCochlear’s recent outlook shift has stirred market reaction, highlighting operational challenges, investor sentiment, and evolving dynamics within Australia’s healthcare stock landscape.
ASX 300 Biotech Stock Completes Capital Raise Move
April 23, 2026 04:00 PM AEST| By SamAn ASX biotech company gains attention after completing a capital raising initiative, supporting ongoing immuno-oncology research and development within Australia’s healthcare sector.
What’s Driving Imugene’s Fresh Capital Push and Market Focus?
April 23, 2026 03:51 PM AEST| By SamImugene strengthens its financial position through a successful capital raise, supporting clinical development and advancing its innovative cancer therapy pipeline amid growing investor interest.
ASX 200 Meltdown: Cochlear’s Record Crash Leaves Investors Reeling
April 23, 2026 03:17 PM AEST| By SamCochlear’s historic share price crash followed a sharp earnings downgrade, erasing billions in value and highlighting growing pressures across the healthcare sector in the Australian share market.
ASX 200 Shockwave: Cochlear Crash Sparks Massive Investor Losses
April 23, 2026 03:15 PM AEST| By SamCochlear’s sharp earnings downgrade triggered a major share price collapse, wiping billions in value and shaking confidence in the ASX healthcare sector amid ongoing global challenges.
ASX 200 Shocker: Cochlear Crash Wipes Out Years of Gains
April 23, 2026 03:11 PM AEST| By SamCochlear’s sharp decline following an earnings downgrade erased significant market value, highlighting volatility in healthcare stocks and shifting investor sentiment across the Australian share market.
ASX 200 Slides as Healthcare Shock Sends Markets on Edge
April 23, 2026 02:47 PM AEST| By SamThe ASX 200 declined as healthcare stocks, including CSL and Cochlear, led a sharp sell-off, while defensive sectors showed resilience amid rising market volatility and shifting investor sentiment.
ASX 200 Healthcare Giant CSL Hits Multi-Year Low—What’s Driving the Slide?
April 23, 2026 02:45 PM AEST| By SamCSL shares fall to multi-year lows as earnings challenges, restructuring plans, and global healthcare shifts drive a reassessment of its growth outlook in the Australian share market.
Warrigal Partnership Positions InteliCare in ASX 200 Aged Care
April 23, 2026 02:16 PM AEST| By Team Kalkine MediaInteliCare expands into retirement living through a Warrigal agreement, deploying monitoring systems across villas and strengthening digital integration in aged care environments.
Why Are CSL Limited (ASX:CSL) and Cochlear (ASX:COH) Influencing ASX 200 Healthcare Stocks?
April 23, 2026 01:57 PM AEST| By SamASX 200 today reflects softer movement as healthcare stocks influence index performance, highlighting sector-driven shifts across the Australian market.
Is ASX All Ordinaries Powering Healthcare Innovation?
April 23, 2026 12:04 PM AEST| By SamHealthcare technology trends within the ASX All Ordinaries highlight digital innovation, global expansion, and evolving market dynamics shaping Australia’s healthcare sector.
Leading ASX 100 Healthcare Stocks to Watch
April 23, 2026 10:26 AM AEST| By SamHealthcare companies including Cochlear, CSL, and ResMed highlight sector activity within the ASX 100 and All Ordinaries, reflecting evolving trends in global medical technology and equity markets.
ASX Biotech Rollercoaster: Why Telix Shares Keep Swinging
April 23, 2026 10:23 AM AEST| By SamTelix shares swing due to strong growth drivers, regulatory uncertainty, and shifting market sentiment, highlighting the balance between opportunity and volatility in the biotech sector.
ASX Healthcare Watch: Little Green Pharma Shares in Focus After Scheme Update
April 22, 2026 06:37 PM AEST| By SamLittle Green Pharma releases a scheme update, signalling ongoing corporate restructuring while highlighting transparency and strategic developments within the evolving healthcare sector.
ASX 200 Entry: Does 4DMedical’s Upgrade Change the Story?
April 22, 2026 05:55 PM AEST| By Sam4DMedical’s ASX 200 inclusion boosts visibility and liquidity, but funding needs and commercial adoption of its lung imaging technology remain key factors shaping its evolving risk and growth narrative.
Is CSL (ASX:CSL) driving ASX 200 healthcare weakness?
April 22, 2026 05:40 PM AEST| By SamHealthcare sector movements and global developments influence ASX market sentiment, with large-cap stocks like CSL shaping broader index dynamics.
ASX 200 Shocker: Cochlear Crash Deepens After Earnings Blow
April 22, 2026 05:36 PM AEST| By SamCochlear shares plunge after a sharp earnings downgrade driven by global headwinds, policy pressures, and weaker demand, highlighting short-term challenges despite ongoing innovation and long-term healthcare demand.
ASX 200 Biotech Under Pressure: Can CSL Stage a Comeback?
April 22, 2026 05:31 PM AEST| By SamCSL faces pressure amid earnings challenges and market rotation, though strong plasma therapy demand and global positioning continue to support its long-term outlook within the healthcare sector.
Why CSL Is Back in Focus Across ASX 100
April 22, 2026 05:24 PM AEST| By SamCSL remains central to Australia’s healthcare sector, with its role in biotechnology and global medical supply shaping its position within major equity indices.
ASX 200 Healthcare Giant Plunges: What’s Behind Cochlear’s Shock Fall?
April 22, 2026 05:18 PM AEST| By SamCochlear shares drop after earnings downgrade driven by weaker demand, hospital constraints, and lower referrals, highlighting near-term pressure despite ongoing innovation and long-term healthcare market opportunities.
Advertise your brand on Kalkine Media